Over the last 50 years, the use of medication-assisted treatment (MAT) for opioid use disorder (OUD) has evolved from a controversial therapy on the outskirts of accepted medical practice and drug abuse prevention strategy to...more
The OIG has indicated concern that patients suffering from opioid use disorder may experience difficulty accessing medication-assisted treatment (MAT), resulting in under-utilization of this intervention that offers what the...more
7/25/2020
/ Audits ,
Coronavirus/COVID-19 ,
Health Care Providers ,
Medicare ,
Medicare Part D ,
Medication-Assisted Treatment (MAT) ,
OIG ,
Opioid ,
SAMHSA ,
Substance Abuse ,
Waivers ,
Work Plans
Congress significantly eased restrictions on disclosing information that identifies substance use disorder (SUD) patients, while simultaneously strengthening protection for SUD patients from discrimination and liability based...more